Amedisys (AMED) reported $591.19 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 6.9%. EPS of $1.32 for the same period compares to $1.37 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $579.34 million, representing a surprise of +2.05%. The company delivered an EPS surprise of +8.20%, with the consensus EPS estimate being $1.22.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stree ...